Glycine Receptors in Cultured Chick Sympathetic Neurons Are Excitatory and Trigger Neurotransmitter Release
Overview
Authors
Affiliations
1. Total RNA isolated from embryonic chick paravertebral sympathetic ganglia was used in a reverse transcription-polymerase chain reaction (RT-PCR) assay with a pair of degenerate oligonucleotide primers deduced from conserved regions of mammalian glycine receptor alpha-subunits. Three classes of cDNA were identified which encode portions of the chicken homologues of the mammalian glycine receptor alpha 1, alpha 2 and alpha 3 subunits. 2. The presence of functional glycine receptors was investigated in the whole-cell configuration of the patch-clamp technique in neurons dissociated from the ganglia and kept in culture for 7-8 days. In cells voltage clamped to -70 mV, glycine consistently induced inward currents in a concentration-dependent manner and elicited half-maximal peak current amplitudes at 43 microM. 3. The steady-state current-voltage relation for glycine-induced currents was linear between +80 and -60 mV, but showed outward rectification at more hyperpolarized potentials. Reversal potentials of these currents shifted with changes in intracellular chloride concentrations and matched the calculated Nernst potentials for chloride. 4. beta-Alanine and taurine were significantly less potent than glycine in triggering inward currents, with half-maximal responses at 79 and 86 microM, respectively. At maximally active concentrations, beta-alanine-evoked currents were identical in amplitude to those induced by glycine. Taurine-evoked currents, in contrast, never reached the same amplitude as glycine-induced currents. 5. The classical glycine receptor antagonist strychnine reversibly reduced glycine-induced currents, with half-maximal inhibition occurring at 62 nM. Two more recently characterized glycine receptor antagonists, isonipecotic acid (half-maximal inhibition at 2 mM) and 7-trifluoromethyl-4-hydroxyquinoline-3-carboxylic acid (half-maximal inhibition at 67 microM), also blocked glycine-evoked currents in a reversible manner. The chloride channel blocker picrotoxin reduced glycine-evoked currents, with half-maximal effects at 348 microM. Inhibition by the glycine receptor channel blocker cyanotriphenylborate was half-maximal at 4 microM. 6. Apart from evoking inward currents, glycine occasionally triggered short (< 100 ms) spike-like currents which were abolished by hexamethonium and thus reflected synaptic release of endogenous acetylcholine. In addition, glycine caused Ca(2+)-dependent and tetrodotoxin-sensitive tritium overflow from neurons previously labelled with [3H]noradrenaline. This stimulatory action of glycine was reduced in the presence of strychnine and after treatment with the chloride uptake inhibitor furosemide (frusemide). 7. In 65% of neurons loaded with the Ca2+ indicator fura-2 acetoxymethyl ester, glycine increased the ratio of the fluorescence signal obtained with excitation wavelengths of 340 and 380 nm, respectively, which indicates a rise in intracellular Ca2+ concentration. 8. The results show that sympathetic neurons contain transcripts for different glycine receptor alpha-subunits and carry functional heteromeric glycine receptors which depolarize the majority of neurons to trigger transmitter release.
Leacock S, Syed P, James V, Bode A, Kawakami K, Keramidas A Front Mol Neurosci. 2018; 11:23.
PMID: 29445326 PMC: 5797729. DOI: 10.3389/fnmol.2018.00023.
Zhang Y, Ho T, Harvey R, Lynch J, Keramidas A Front Mol Neurosci. 2017; 10:158.
PMID: 28588452 PMC: 5440463. DOI: 10.3389/fnmol.2017.00158.
P2Y1 receptors mediate an activation of neuronal calcium-dependent K+ channels.
Schicker K, Chandaka G, Geier P, Kubista H, Boehm S J Physiol. 2010; 588(Pt 19):3713-25.
PMID: 20679351 PMC: 2998222. DOI: 10.1113/jphysiol.2010.193367.
Gartz Hanson M, Landmesser L J Neurosci. 2003; 23(2):587-600.
PMID: 12533619 PMC: 6741864.
Beta-alanine and taurine as endogenous agonists at glycine receptors in rat hippocampus in vitro.
Mori M, Gahwiler B, Gerber U J Physiol. 2002; 539(Pt 1):191-200.
PMID: 11850512 PMC: 2290126. DOI: 10.1113/jphysiol.2001.013147.